Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Tempus AI, Inc. - SIC # 8071 - MEDICAL LABORATORIES
Ticker
Exchange
SIC #
Website
Latest Ticker
TEM
Nasdaq
8071
www.tempus.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Tempus AI, Inc.
Natera Partners With TransCode to Advance Colorectal Cancer Trial
- Oct 21st, 2026 7:16 am
Should You Be Worried About Tempus AI Stock?
- Oct 20th, 2026 5:03 am
Tempus Presents Data Demonstrating AI-Enabled Pre-Screening Can Help Identify Patients for Biomarker Testing in NSCLC
- Oct 19th, 2026 1:03 pm
The AI Trade Just Moved Into Your Bloodstream, and 4 Healthcare Stocks Are Winning
- Oct 19th, 2026 8:30 am
Here's How Tempus AI Demonstrates Improving Operating Leverage
- Oct 19th, 2026 7:00 am
Tempus AI Stock Is The Expanded Drug Collaboration Material To The Bull Case
- Oct 16th, 2026 8:16 pm
Tempus to Report Third Quarter 2026 Financial Results on November 2
- Oct 15th, 2026 2:01 pm
Ambry Genetics Announces GenomeNextâ„¢, a Whole Genome Sequencing Test Solution to Improve Diagnosis for Rare Diseases
- Oct 13th, 2026 4:00 am
Tempus AI Expands Strategic Collaborations to Drive Future Growth
- Oct 12th, 2026 8:46 am
Could You Have Seen The Run In Tempus AI Stock Coming?
- Oct 9th, 2026 8:19 am
Should You Buy, Hold or Sell Tempus AI Stock Amid AI Boom?
- Oct 9th, 2026 6:51 am
Tempus Announces Multi-Year Collaboration with Moderna and Merck
- Oct 7th, 2026 6:30 am
Dow Jones Futures Fall, Yields Jump After S&P 500 Hits High; Astera, GE Vernova, Arista Lead Buys
- Oct 7th, 2026 6:03 am
Fortune Unveils the "Fortune Future 120" 2026 List
- Oct 6th, 2026 6:00 am
Tempus AI (TEM) Shares Just Moved, So What Is Going On?
- Oct 5th, 2026 11:07 pm
Here's How Tempus AI is Capitalizing on AI-ECG Market Growth
- Oct 5th, 2026 8:03 am
AI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment
- Oct 1st, 2026 10:11 am
Tempus Announces 13 Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2026
- Oct 1st, 2026 6:34 am
Cathie Wood Sold $110 Million of AMD and Bought Nvidia Instead
- Sep 30th, 2026 7:16 am
Providence Therapeutics Announces Formation of Oncology Clinical Advisory Board
- Sep 29th, 2026 5:00 am
Scroll